Angiotensin receptor blockers vs. beta-blocker therapy for Marfan syndrome: a systematic review and meta-analysis

Z Wang, X Deng, X Kang, A Hu - Annals of Vascular Surgery, 2022 - Elsevier
Objective Several RCTs have been conducted to assess the efficacy and safety of
angiotensin receptor blocker (ARB) and beta-blocker (BB) therapy for Marfan syndrome …
被引用次数：9 相关文章

Angiotensin Receptor Blockers vs. Beta-Blocker Therapy for Marfan Syndrome: A Systematic Review and Meta-Analysis.

Z Wang, X Deng, X Kang, A Hu - Annals of Vascular Surgery, 2022 - europepmc.org
Objective Several RCTs have been conducted to assess the efficacy and safety of
angiotensin receptor blocker (ARB) and beta-blocker (BB) therapy for Marfan syndrome …

Angiotensin Receptor Blockers vs. Beta-Blocker Therapy for Marfan Syndrome: A Systematic Review and Meta-Analysis

Z Wang, X Deng, X Kang, A Hu - Annals of vascular …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective Several RCTs have been conducted to assess the efficacy and safety of
angiotensin receptor blocker (ARB) and beta-blocker (BB) therapy for Marfan syndrome …